Dare Bioscience
DARE · NASDAQ
$0.689+$0.0207 (+3.10%)TodayMarket closed ·
Prev close $0.6683
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 33.8% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.2499 | -$0.20 | +20.0% |
| Q1 FY26 | -$0.2958 | -$0.20 | +32.4% |
| Q4 FY25 | -$0.4412 | -$0.02 | +95.5% |
| Q3 FY25 | -$0.3638 | -$0.28 | +23.0% |
| Q2 FY25 | -$0.5916 | -$0.45 | +23.9% |
| Q1 FY25 | -$0.5916 | -$0.50 | +15.5% |
| Q4 FY24 | -$0.544 | -$0.65 | −19.5% |
| Q3 FY24 | -$0.748 | -$0.55 | +26.5% |
Earnings calls
- Special Call - Daré Bioscience, Inc.
- DARE - Earnings call Q2 2026
- Special Call - Daré Bioscience, Inc.
- Special Call - Daré Bioscience, Inc.
- Special Call - Daré Bioscience, Inc.
- DARE - Earnings call Q1 2026
- 2025 Earnings Call
- Special Call - Daré Bioscience, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.